Johnson & Johnson Segments Total — Total Assets decreased by 0.1% to $164.30B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.2%, from $143.84B to $164.30B.
An increase suggests capital expansion or acquisition activity, while a decrease may indicate asset divestiture or improved capital efficiency.
This metric represents the aggregate book value of all resources controlled by the business segments, including property...
Comparable to total assets reported by diversified healthcare conglomerates or large-cap industrial peers.
jnj_segment_segments_total_assets| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $142.83B | $129.39B | $133.03B | $141.39B | $143.84B | $162.23B | $160.92B | $164.54B | $164.30B |
| QoQ Change | — | -9.4% | +2.8% | +6.3% | +1.7% | +12.8% | -0.8% | +2.2% | -0.1% |
| YoY Change | — | -9.4% | +2.8% | +6.3% | — | — | — | +16.4% | +14.2% |